Adding a Corticosteroid or Switching to Another Anti-VEGF in Insufficiently Responsive Wet Age-Related Macular Degeneration
Cagdas Kaya,1 Souska Zandi,1,3 Isabel B Pfister,1,2 Christin Gerhardt,1,2 Justus G Garweg1,2 1Swiss Eye Institute, Rotkreuz, and Berner Augenklinik am Lindenhofspital, Bern, Switzerland; 2Department Ophthalmology, University Hospital Bern, Bern, Switzerland; 3Department of Ophthalmology, Inselspital...
Main Authors: | Kaya C, Zandi S, Pfister IB, Gerhardt C, Garweg JG |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-12-01
|
Series: | Clinical Ophthalmology |
Subjects: | |
Online Access: | https://www.dovepress.com/adding-a-corticosteroid-or-switching-to-another-anti-vegf-in-insuffici-peer-reviewed-article-OPTH |
Similar Items
-
Incidence of endophthalmitis after intravitreal application of anti VEGF therapy at the University Clinical Center in Tuzla, Bosnia and Herzegovina
by: Svjetlana Terzić, et al.
Published: (2015-08-01) -
Short-Term Outcomes of Refractory Diabetic Macular Edema Switch From Ranibizumab to Dexamethasone Implant and the Influential Factors: A Retrospective Real World Experience
by: Ning-Yi Hsia, et al.
Published: (2021-04-01) -
Repeated Treatment for Macular Edema in Vein Occlusion by Intravitreal Implant of Dexamethasone
by: Frederic Matonti, et al.
Published: (2012-10-01) -
Intravitreal Dexamethasone Implant in the Treatment of Non-infectious Uveitis
by: Murat Hasanreisoğlu, et al.
Published: (2019-10-01) -
Acute bacterial endophthalmitis following dexamethasone intravitreal implant: A case report
by: Waseem Al Zamil, et al.
Published: (2019-01-01)